BSE filing, NSE: AFEL. Summary written from the filing by ALFA Finder's alert engine.
A F Enterprises Ltd: key numbers
- Share price
- ₹1.83
- Market cap
- ₹3.55 Cr
- Revenue (annual)
- ₹8.50 Cr
- Net profit (annual)
- ₹0.18 Cr
- P/E (TTM)
- -3.5×Sector 51.9×
- Promoter holding
- 2.42%+0.13% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from A F Enterprises Ltd
All →A F Enterprises Board Meeting Date
A.F. Enterprises will meet on 14 November 2026 to consider unaudited quarterly results for September 2026. Trading window stays closed until results are declared.
A F Enterprises Other Announcement
A.F. Enterprises filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and public holdings are reported for the quarter.
A F Enterprises Other Announcement
AF Enterprises Ltd has filed the certificate under Regulation 74(5) for the quarter ended September 30, 2026, confirming compliance with SEBI's depository requirements.
A F Enterprises Other Announcement
The company filed its quarterly shareholding pattern for the period ended December 31, 2025, in compliance with SEBI Regulation 31.
A F Enterprises Board Meeting Outcome
AF Enterprises Ltd announced the withdrawal of CIRP proceedings per an NCLT order. Management control has officially reverted back to the company.
A F Enterprises Insolvency Petition
AF Enterprises Ltd announced the withdrawal of the CIRP against it by the NCLT. A settlement agreement for Rs. 3 Crore was executed, terminating the insolvency process.
- Value
- ₹3.00 Cr
Other other announcement announcements
All →Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.
Schaeffler India Other Announcement
Schaeffler India disclosed that CRISIL ESG Ratings assigned it an ESG Score of 67 on an unsolicited basis. The company did not engage or subscribe to the rating provider.